Clinical Trial Update: A Trial of Low-dose Adjunctive alTeplase During prIMary PCI [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating low-dose adjunctive alTeplase during primary PCI in myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Alteplase (alteplase)

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Myocardial Infarction | Phase 2 | Status: COMPLETED